Emmaus Life Sciences, Inc. (EMMA) stock
EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
$0.05−0.01 (-14.38%)
Close on Oct 19, 2026Market cap $6.03MP/E –Yield –
Emmaus Life Sciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Emmaus Life Sciences's price to sales ratio was 0.2× on Oct 19, 2026, against 0.0× a year earlier. Over the last 5 years it ranged from 0.0× to 4.4×, with a median of 0.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 0.2× | +0.2 |
| 2025 | Dec 31, 2025 | 0.0× | +0.0 |
| 2024 | Dec 31, 2024 | 0.0× | −0.2 |
| 2023 | Dec 29, 2023 | 0.2× | −0.6 |
| 2022 | Dec 30, 2022 | 0.8× | −2.6 |
| 2021 | Dec 31, 2021 | 3.5× | +1.4 |
| 2020 | Dec 31, 2020 | 2.0× | −248.9 |
| 2019 | Apr 30, 2019 | 250.9× | +104.0 |
| 2018 | Dec 31, 2018 | 146.9× | −350.1 |
| 2017 | Aug 31, 2017 | 497.0× | +496.9 |
| 2016 | Dec 30, 2016 | 0.1× | −184.2 |
| 2015 | Dec 31, 2015 | 184.3× | +172.7 |
| 2012 | Oct 31, 2012 | 11.6× | −33.6 |
| 2011 | Dec 30, 2011 | 45.2× | −165.4 |
| 2010 | Dec 31, 2010 | 210.6× | – |
See a number that looks wrong?